Michelle Greenman

VP, Global Regulatory Affairs at Kezar Life Sciences

Michelle Greenman is Vice President of Global Regulatory Affairs. She is responsible for leading the regulatory affairs team, managing regulatory operations and medical writing resources, and strategic regulatory planning for Kezar’s assets. Prior to joining Kezar in June 2020, Ms. Greenman served as Global Regulatory Lead for Retrophin (now, Travere Therapeutics). Ms. Greenman has held positions of increasing responsibility at Vital Therapies, Shire Regenerative Medicine, and Advanced BioHealing and gained experience with small molecule drug development, combination products (biologics and medical devices), advertising and promotional reviews, post-marketing commercial support and application maintenance. Most of her career in regulatory affairs has been spent working in the rare disease space.

Ms. Greenman earned her bachelor’s degree in Biology from Gustavus Adolphus College and her Doctor of Chiropractic degree from Northwestern Health Sciences University.

Location

Scottsdale, United States

Links


Org chart


Teams


Offices

This person is not in any offices


Kezar Life Sciences

Based in South San Francisco, Kezar Life Sciences is combining courage, conviction and cutting-edge science to develop breakthrough treatments for immune-mediated and oncologic disorders–with the hope of helping people overcome their disease and live a better life.


Industries

Employees

11-50

Links